Featured Interview: CEO Alex Wasyl of Nexien BioPharma, Inc. (OTCQB: NXEN)

CEO Alex Wasyl of Nexien BioPharma, Inc., discusses recent acquisition, consolidation, and being engaged in the formulation, development, and commercialization of cannabinoid based drugs.

Read more